Skip to content
★ Sign in to follow
SA

SkåneÖrnen AB

Related company / holding
PharmaLundensis ABPhal
Insider activity · 24 months1 buy0 salesCumulative net flow
Total declarations
27
Companies
2
▲ Purchases (22 ops.)
€200k
▼ Sales (0 ops.)
—

Latest filing published 10 Mar 2025 for PharmaLundensis AB, €18k.

Filing timeline

BuySale
SkåneÖrnen AB

Insider track record

Disclosed buys
22
Disclosed sells
0
Signal history

Closed purchases

Market purchases
22

Not enough history yet: 0 closed purchases, at least 2 are needed.

Purchases by company

SkåneÖrnen AB: trading record in brief

This profile gathers the share dealings of SkåneÖrnen AB across 2 companies, led by PharmaLundensis AB and Phal. In total, 27 filings cover trades dated from 19 March 2021 to 27 February 2025.

On the market, this insider has only ever bought: 22 purchases, €200k in total. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Since January 2025: 1 purchase and no sales on the market.

Half of the purchases are above €2,787 and half below. On 7 out of 18 purchases, another insider of the same company was buying within the same 30 days. A cluster is several different insiders buying the same stock within a short window, a pattern studied more closely than a single purchase.

The newest entry dates from 10 March 2025: a transaction of €18k, in PharmaLundensis AB. The last insider purchase was made public on 21 January 2025, 656 days ago. Filings reach the Finansinspektionen feed a median of 3 days after the trade. The regulation allows three business days to notify a trade (MAR article 19). This summary is built from Finansinspektionen disclosures alone and does not predict where the share price will go.

Companies and markets linked to SkåneÖrnen AB

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations27 total
  • ●
    Related company / holdingExecutivesPharmaLundensis AB
    200,000 SEK30FI-SE
    200,000 shares@ SEK 1.000.98% mcap100.0% of flowAktieISIN SE0023875083FI:A003M347-1
  • ▲
    Related company / holdingExecutivesPhal
    96,143 SEK30FI-SE
    121,700 shares@ SEK 0.7983.3% of flowAktieISIN SE0003359710FI:csv-4bb59d51286e54eb041d
    Canonical exit: 17 Apr 2025 (T+90)
  • ▲
    Related company / holdingExecutivesPharmaLundensis AB
    19,748 SEK37FI-SE
    49,370 shares@ SEK 0.400.3% of flowAktieISIN SE0003359710FI:csv-971461bc2d35cb9288a6
    Canonical exit: 12 Jan 2025 (T+90)
  • ▲
    Related company / holdingExecutivesPharmaLundensis AB
    29,610 SEK37FI-SE
    63,000 shares@ SEK 0.470.4% of flowAktieISIN SE0003359710FI:csv-c609cc680d05123dfe16
    Canonical exit: 25 Dec 2024 (T+90)
  • ●
    Related company / holdingExecutivesPharmaLundensis AB
    2M SEK0FI-SE
    3,999,999 shares@ SEK 0.5028.1% of flowBTU (betald tecknad unit)ISIN SE0022727244FI:csv-47bfff68d4b0405c4efb
  • ▲
    Related company / holdingExecutivesPharmaLundensis AB
    22,801 SEK34FI-SE
    50,668 shares@ SEK 0.450.3% of flowAktieISIN SE0019912783FI:csv-14fb3c6cdd1e28b1e2d2
    Canonical exit: 12 Dec 2024 (T+90)
  • ▲
    Related company / holdingExecutivesPharmaLundensis AB
    21,080 SEK22FI-SE
    34,500 shares@ SEK 0.6110.3% of flowAktieISIN SE0019912783FI:csv-de735dc6179451a0fd4f
    Canonical exit: 19 May 2024 (T+90)
  • ▲
    Related company / holdingExecutivesPhal
    18,712 SEK30FI-SE
    51,979 shares@ SEK 0.36100.0% of flowAktieISIN SE0019912783FI:csv-f629d66ca403deeec8ac
    Canonical exit: 20 Mar 2024 (T+90)
  • ▲
    Related company / holdingExecutivesPharmaLundensis AB
    32,779 SEK0FI-SE
    99,330 shares@ SEK 0.330.5% of flowBTU (betald tecknad unit)ISIN SE0019912783FI:csv-c04d872c5ca3c0bee936
    Canonical exit: 12 Mar 2024 (T+90)
  • ▲
    Related company / holdingExecutivesPharmaLundensis AB
    25,856 SEK0FI-SE
    66,297 shares@ SEK 0.390.4% of flowBTU (betald tecknad unit)ISIN SE0019912783FI:csv-d4e083929eb0052fc205
    Canonical exit: 13 Mar 2024 (T+90)
  • ●
    Related company / holdingExecutivesPharmaLundensis AB
    160,000 SEK0FI-SE
    320,000 shares@ SEK 0.502.2% of flowBTU (betald tecknad unit)ISIN SE0019912783FI:csv-c9639d363deb475298eb
  • ●
    Related company / holdingExecutivesPharmaLundensis AB
    1M SEK0FI-SE
    2,021,952 shares@ SEK 0.5013.8% of flowBTU (betald tecknad unit)ISIN SE0019912783FI:csv-fe38791c575ca1738954
  • ▲
    Related company / holdingExecutivesPharmaLundensis AB
    391 SEK22FI-SE
    868 shares@ SEK 0.450.0% of flowAktieISIN SE0019912783FI:csv-0adc4ddd8b32f3b683e1
    Canonical exit: 5 Feb 2024 (T+90)
  • ▲
    Related company / holdingExecutivesPharmaLundensis AB
    18,750 SEK22FI-SE
    41,667 shares@ SEK 0.450.3% of flowAktieISIN SE0019912783FI:csv-333646f333323e1e68a8
    Canonical exit: 1 Feb 2024 (T+90)
  • ▲
    Related company / holdingExecutivesPharmaLundensis AB
    1,349 SEK22FI-SE
    2,998 shares@ SEK 0.450.0% of flowAktieISIN SE0019912783FI:csv-5f0485793b8becb12953
    Canonical exit: 29 Jan 2024 (T+90)
  • ▲
    Related company / holdingExecutivesPharmaLundensis AB
    30,800 SEK22FI-SE
    40,000 shares@ SEK 0.770.4% of flowAktieISIN SE0019912783FI:csv-7b2853394ecc4e5c65a0
    Canonical exit: 15 Jan 2024 (T+90)
  • ▲
    Related company / holdingExecutivesPharmaLundensis AB
    154,280 SEK22FI-SE
    241,063 shares@ SEK 0.642.1% of flowAktieISIN SE0019912783FI:csv-b4c594b6e7bb591e92e1
    Canonical exit: 11 Jan 2024 (T+90)
  • ▲
    Related company / holdingExecutivesPharmaLundensis AB
    60,011 SEK22FI-SE
    64,528 shares@ SEK 0.930.8% of flowAktieISIN SE0019912783FI:csv-7317592c3e3a18d52d65
    Canonical exit: 5 Dec 2023 (T+90)
  • ▲
    Related company / holdingExecutivesPharmaLundensis AB
    134,887 SEK22FI-SE
    224,812 shares@ SEK 0.601.8% of flowAktieISIN SE0019912783FI:csv-105ad7e869e2971262b5
    Canonical exit: 4 Dec 2023 (T+90)
  • ▲
    Related company / holdingExecutivesPharmaLundensis AB
    47,623 SEK22FI-SE
    136,067 shares@ SEK 0.350.6% of flowAktieISIN SE0019912783FI:csv-72a2d999df1b7fdf4c54
    Canonical exit: 22 Nov 2023 (T+90)
  • ▲
    Related company / holdingExecutivesPharmaLundensis AB
    17,690 SEK34FI-SE
    50,542 shares@ SEK 0.350.2% of flowAktieISIN SE0019912783FI:csv-d17a090b2fb51b43af26
    Canonical exit: 2 Oct 2023 (T+90)
  • ●
    Related company / holdingExecutivesPharmaLundensis AB
    2M SEK0FI-SE
    3,186,466 shares@ SEK 0.5022.6% of flowBTU (betald tecknad unit)ISIN SE0019912783FI:csv-2ccbe030f65c2bacc0be
  • ▲
    Related company / holdingExecutivesPharmaLundensis AB
    810,000 SEK0FI-SE
    270,000 shares@ SEK 3.0012.5% of flowBTU (betald tecknad unit)ISIN SE0017767528FI:csv-e4d9d62667666de7ad70
    Canonical exit: 13 Jul 2022 (T+90)
  • ▲
    Related company / holdingExecutivesPharmaLundensis AB
    37,696 SEK34FI-SE
    38,000 shares@ SEK 0.9920.6% of flowAktieISIN SE0003359710FI:csv-c7be0b04ed6cb5f4a2de
    Canonical exit: 7 Jul 2022 (T+90)
  • ▲
    Related company / holdingExecutivesPharmaLundensis AB
    42,527 SEK34FI-SE
    45,728 shares@ SEK 0.930.6% of flowAktieISIN SE0003359710FI:csv-142b7d36936ddb150f4d
    Canonical exit: 21 Jun 2022 (T+90)

25 of 27 declarations